PharmEasy raises $300 million to acquire Thyrocare

E-pharmacy unicorn PharmEasy raised about $300 million from its existing investors last month, in order to aid the acquisition of public-listed diagnostic chain Thyrocare for ₹4,546 crore ($612 million). TPG, Singapore’s Temasek, Facebook cofounder Eduardo Saverin’s B Capital, Prosus and Think Investments participated in this round. The company also noted that it will be looking to hit the public market in the next six to 18 months.